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Major components of the secretory organelle of bovine adrenal medullary cells, the chromaffin vesicles, are the acidic 
protein chromogranin A, catecholamines and Caz+. The binding of Ca*+ to chrom o g ranin A has been established. To 
study the interaction between chromogranin A and catecholamines and its dependence on Ca*’ we immobilized chromo- 
granin A to a newly raised monoclonal antibody. It is shown that chromogranin A can bind (i) about 0.5 mol catechol- 
amines per mol in a non-calcium-dependent manner and (ii) about 5 mol per mol in the presence of calcium. These results 
further support the notion that chromogranin A may act as a secretory granule-condensing protein. 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
Chromogranins (CHR) are acidic, soluble pro- 
teins of the catecholamine (CA) storing vesicles in 
adrenal medullary cells [1,2] which are secreted 
together with CA. Despite the fact that their 
biochemical properties are well characterized 
[3-51, their biological function(s) is (are) 
unknown. It has been proposed that they may act 
as huxmtme-s;Deti%c r>r oleases, as hormone r>re#x - 
sors, and, because of their Ca”-binding I&73 and 
aggregating properties, as secretory vesicle- 
condren%nj _ro;lPm5 >%.Z$. Tbt 5&l amii~anxx 
and co-storage of CHR, CA and Ca2+ in chromaf- 
fin granules prompted us to analyze the putative 
interaction between these three groups of 
molecules. We raised a monoclonal antibody 
against bovine CHR-A which was used for both 
CHK-A purification and as a sdnd support Ior 
CHK-A m the binding studies. 
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2.1. Materials 
Cell culture medium (Iscove’s medium) was obtained from 
Seromed (Berlin). Myoclone fetal calf serum was from Gibco 
(Karlsruhe, FRG); cell culture plastic material from Falcon 
(Becton and Dickinson, Heidelberg, FRG); and Sepharose 4B 
from Pharmacia (.Freiburg, FRG). All other chemicals were of 
analytical grade and obtained from Sigma, Hoeechst or Merck 
(Munich, Frankfurt, Darmstadt, FRG). 
2.2. Methods 
Bovine chromaffin ceff vesicles were isofated according to 
Winkler and Smith [IO] with the exoeption &at &e >asr cen- 
trifugation step was performed with a 1.7 M instead of 1.6 M 
s~nxre Fu&i&n .Si%_m ‘iv&-iii-~i~\~~*~ ,ekhsw-eii~vA 
in 5 mM phosphate, pH 6.5, and centrifuged for 30 min at 
100000 x g. The supernatant was extensively dialysed against 
+sis &a%%~ && s%vbq*&~ agZ&>t .JakkP2~2~d W.&T a.& 
Ly~philized or directly k&-d onto the a~&CHR-A affinity Cal- 
umn. Determination of protein [l 1] and CA [12] as well as the 
preparation of immunoadsorbents [13] were performed as 
~&~+.rz& B% $9~ ‘y,-~ti&n~ ti mm&maI> snj&o.&fia., 
temal‘e BatB/L’ mice were intected with purified bovine 
&YXXI%~ && >A+ ,iT ~+&e>~ iX**&. 0 &y> &* h-+ :\r - 
travenously applied booster injection isolated spleen cells were 
fused to myeloma cells (ratio 2: 1) using PEG 4000 1151. Culture 
supernatants were screened by enzyme-linked immunosorbent 
assays (ELISA) [16], immunofluorescence and immunoblotting 
[17,18]. After stringent recloning and mass culture one 
hybridoma line (7Al/H3) was injected into pristane-primed 
mice for ascites production. 
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3. RESULTS AND DISCUSSION 
3.1. Characterization of the monoclonal antibody 
against bovine chromogranin A 
The antibody (MAB 7Al/H3) which belongs to 
the IgGl subclass was identified to be specific to 
CHR-A and its degradation products based on the 
following lines of evidence: (i) in one- and two- 
dimensional immunoblots the molecular mass and 
plof the main band (75 kDa, 5.0, fig. 1) are similar 
to CHR-A (75 kDa, 5.0) but different from CHR- 
B (100 kDa, 5.2) and secretogranin II (= CHR-C, 
86 kDa, 5.0) [3,4]; (ii) in two-dimensional im- 
munoblots the pattern is identical to that obtained 
with a polyclonal antiserum monospecific for 
CHR-A (fig.lb); but, (iii) clearly different from 
anti-CHR-B and anti-secretogranin II patterns 
(fig.lc,d); (iv) proteins obtained by affinity 
chromatography with MAB 7Al/H3 are reactive 
with the polyclonal anti-CHR-A antiserum (fig.2a) 
and show a main band of 75 kDa (fig.2b); (v) these 
proteins are also different from prominent en- 
zymes of chromaffin cells (dopamine-fl-hydroxy- 
lase and phenylethanolamine-N-methyltransfer- 
ase) as revealed by enzyme- and immunoassays 
(Seidl, K., personal communication); and, (vi) im- 
munohistochemical label on bovine chromaffin 
cells is restricted to vesicles (fig.3). Since no cross- 
reactivity with human or rat CHR-A was detec- 
table (fig.4), MAB 7Al/H3 appears to be specific 
Fig.1. Comparison of 2D immunoblots of soluble bovine 
chromaffin granule proteins incubated with (a) MAB 7Al/H3, 
(b) anti CHR-A, (c) anti CHR-B, or (d) secretogranin I1 
(= CHR-C) shows similar patterns for MAB 7Al/H3 and anti 
CHR-A. 
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Fig.2. Characterization of proteins obtained by affinity 
chromatography of soluble chromaffin vesicle content on a 
MAB 7Al/H3 column. Dialyzed vesicle content was passed 
over the antibody column. The bound proteins were eluted and 
further separated by gel filtration on an FPLC-Superose 
column (a, -). An ELISA using the polyclonal anti-CHR-A 
antiserum shows strong immunoreactivity for FPLC fractions 
3-5 (a, -). Separation by SDS-electrophoresis of FPLC 
fractions 2-15 (b, left to right) reveals the presence of 4 proteins 
of 75, 63, 57, and 53 kDa in fractions 3 and 4 (arrowheads) 
indicating that most, if not all protein bound to the MAB 
7Al/H3 column corresponds to CHR-A and its degradation 
products (arrow in b, molecular mass marker proteins of 66,45, 
34, 20.1, and 12.4 kDa). 
to bovine CHR-A. For quantitative determination 
a competitive ELISA with a detection limit of 
about 1 ng was established (fig.5). 
3.2. Catecholamine binding to immobilized 
chromogranin A 
The protein CHR-A is one of the most promi- 
nent constituents of bovine chromaffin vesicles 
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Fig.3. Immunohistochemistry of MAB 7Al/H3 on cultured 
bovine chromaffin cells shows a granular intracellular 
distribution of the antigen. 
[1,2,10]. It was proposed that CHR-A is a 
secretory granule-condensing protein because of its 
ability to bind Ca*+ [6-91. Besides CHR-A and 
Ca*+ , CA are the most abundant molecules present 
in bovine chromaffin vesicles. We therefore first 
investigated the CA-binding capacity of im- 
mobilized CHR-A in the absence of Ca*+. The 
MAB was coupled to BrCN-activated Sepharose 
4B and loaded in succession with (i) saturating 
amounts of immunoaffinity-purified CHR-A and 
(ii) a pulse of 600 ,ug adrenaline. Elution of CA- 
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Fig.4. Species specificity of MAB 7Al/H3 for bovine CHR-A 
is evident from an ELISA with soluble bovine chromaffin 
vesicle proteins (1 pg/well, -) and extracts from adrenal 
glands (70pg/well) of rat (O---O) and man (s). 
Fig.5. Typical standard curve obtained by the competitive 
ELISA for CHR-A with MAB 7Al/H3. Antibody was diluted 
1:50000 in phosphate buffered saline with the indicated 
amounts of affinity-purified CHR-A and incubated overnight 
at 4°C. Following centrifugation the supernatant was 
transferred to CHR-A-precoated (10 ng/well) microtiter plates, 
incubated for 20 min at room temperature and further 
processed as in normal ELISA. Data represent mean values of 
a triple estimation. 
CHR-A complexes with 50 mM glycine-HCl, pH 
2.0, showed a distinct peak containing CHR-A as 
well as CA (fig.6). Quantitation by the CHR-A 
competitive ELISA and CA-HPLC revealed a 
molar ratio of 1:0.5 for CHR-A to adrenaline. 
These results clearly demonstrate the ability of 
CHR-A to bind low, but significant amounts of 
CA. 
3.3. Catecholamine binding in the presence of 
cd’+ 
To analyze the effects of Ca*+ on CA binding, 
the immunoaffinity column was equilibrated over- 
night with undialyzed vesicle content, i.e. in the 
presence of physiological relations of CHR-A, 
CA, and Ca2+. Elution with a Ca*+ gradient from 
0.05 to 1.0 M resulted in a rapid release of only 
CA, while during removal of Ca*+ by EDTA and 
elution of CHR-A with glycine-HCl distinct peaks 
containing CHR-A and CA were observed (fig.7). 
The total amount of bound CA to CHR-A cor- 
responded to a molar ratio of about 5 : 1. Results 
demonstrate that bovine CHR-A not only binds 
Ca*+ but also CA. Attached via a high-affinity 
205 
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Fig.6. Elution profiles of CHR-A and CA in the absence of 
Ca**. Bovine CHR-A was bound to the MAB 7Al/H3 
immunoaffinity column and unbound material washed off with 
10 mM Tris-HCl, pH 7.0. Then a pulse of 600 pg adrenaline/ml 
(arrowhead a) was given and unbound adrenaline washed off 
with Tris buffer. The CHR-A-CA complexes were eluted with 
50 mM glycine-HCl, pH 2.0 (arrowhead b), and CHR-A as well 
as adrenaline quantified by competitive ELISA or HPLC, 
respectively. A molar ratio of 0.5: 1 for CA/CHR-A was 
observed. (-) Absorbance at 280 nm; (- ) adrenaline 
concentration. 
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Fig.7. Elution profiles of CHR-A and CA in the presence of 
Ca2+. The MAB 7Al/H3 immunoaffinity column was 
equilibrated overnight with total, undialyzed soluble 
chromaffin vesicle content. Unbound material was removed by 
washing with 10 mM phosphate buffer, pH 6.6, containing CA 
(25 ng adrenaline/ml) and Ca*+ (50 pM). Immediately after 
starting a linear Ca*+ gradient (arrowhead a) a CA peak was 
observed, while nearly no CHR-A was detectable. Coelution of 
CHR-A and CA occurred during removal of Ca*+ with 0.1 M 
EDTA (arrowhead b) and elution with 50 mM glycine-HCl, pH 
2.0 (arrowhead c). Quantification of CHR-A as well as CA 
showed a total ratio of 5: 1 for CA/CHR-A. (-) 
Absorbance at 280 nm; ( M) adrenaline concentration. 
monoclonal antibody to a solid phase, CHR-A can 
bind only minor quantities of CA in the absence of 
Ca2+ (0.5 mol CA per mol CHR-A, assuming a 
molecular mass of 75 kDa). In the presence of 
Ca2+ (up to 100 pm, see fig.7) the binding ratio in- 
creased by a factor of 10 (5 mol CA per mol CHR- 
A). These findings support the hypothesis that 
CHR-A may act as a secretory granule condensing- 
protein to reduce osmotic pressure during storage 
of small molecules like CA [8,9]. 
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